FDA is expected to assign a Prescription Drug User Fee Act (PDUFA) target action date and announce whether Priority Review…
EYLEA HD demonstrated non-inferior vision gains with an every 8-week dosing regimen compared to EYLEA® (aflibercept) Injection 2 mg dosed…
NEW YORK, Dec. 15, 2024 /PRNewswire/ -- The global online therapy services market size is estimated to grow by USD 16.16 billion…
Pre-Money Valuation of JPY9 Billion is Approximately Multiples of Current Parent Company Market Capitalization.Strategic Investors Further Validation of Technology and…
The report from The Insight Partners lists several stakeholders—including healthcare providers, government agencies and health authorities, insurance providers, and academic…
SEATTLE, WA / ACCESSWIRE / December 12, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO) ("Aptevo" or the "Company"), a clinical-stage biotechnology…
MIAMI, Dec. 12, 2024 /PRNewswire/ -- Healthy Together, a leading provider of cloud-based Software-as-a-Service (SaaS) solutions, has announced its expanded…
-- New research demonstrates integrating AI-enabled, health record data insights with targeted educational interventions can enhance understanding and management of…
Two of three patients achieved both complete remission and MRD-negative statusHigh response rates observed in earlier studies continue in ongoing…
OCALA, Fla., Dec. 12, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that…